Publication Name	World Journal of Clinical Cases
Manuscript ID	97850
Country	China

Received	2024-06-11 02:33
Peer-Review Started	2024-06-11 02:33
To Make the First Decision
Return for Revision	2024-07-17 21:14
Revised	2024-07-26 09:07
Second Decision	2024-07-31 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-07-31 08:47
Articles in Press	2024-07-31 08:47
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-08-06 21:28
Typeset the Manuscript	2024-08-23 07:41
Publish the Manuscript Online	2024-09-24 02:54

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Editorial
Article Title	Evolving of treatment options for cerebral infarction
Manuscript Source	Invited Manuscript
All Author List	Qiong-Yue Cao and Zheng Li
ORCID	Author(s) ORCID Number Zheng Li http://orcid.org/0000-0002-2882-6600
Funding Agency and Grant Number
Corresponding Author	Zheng Li, PhD, Lecturer, Pharmacist, Jiangsu Engineering Research Center of Cardiovascular Drugs Targeting Endothelial Cells, College of Health Sciences, School of Life Sciences, Jiangsu Normal University, No. 101 Shanghai Road, Xuzhou 221000, Jiangsu Province, China. lizhengcpu@163.com
Key Words	Cerebral infarction; Treatment; Thrombolytic therapy; Aspirin; Edaravone; Natural medicine
Core Tip	Over the last few decades, the treatment for cerebral infarction (CI) have undergone a dramatic evolution from pharmacological drugs. This editorial focuses on the progress in treatment options for CI. We hope that this editorial could provide valuable information for the treatment of CI.
Publish Date	2024-09-24 02:54
Citation	<p>Cao QY, Li Z. Evolving of treatment options for cerebral infarction. <i>World J Clin Cases</i> 2024; 12(32): 6534-6537</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i32/6534.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i32.6534

Full Article (PDF)	WJCC-12-6534-with-cover.pdf
Manuscript File	97850_Auto_Edited_011151.docx
Answering Reviewers	97850-answering-reviewers.pdf
Audio Core Tip	97850-audio.mp3
Conflict-of-Interest Disclosure Form	97850-conflict-of-interest-statement.pdf
Copyright License Agreement	97850-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	97850-non-native-speakers.pdf
Peer-review Report	97850-peer-reviews.pdf
Scientific Misconduct Check	97850-scientific-misconduct-check.png
Scientific Editor Work List	97850-scientific-editor-work-list.pdf
CrossCheck Report	97850-crosscheck-report.pdf
CrossCheck Report	97850-crosscheck-report.png